# Postoperative Consequences of Intraoperative NOL Titration

> **NCT04679818** · PHASE3 · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 72 (actual)

## Conditions studied

- Anesthesia; Adverse Effect

## Interventions

- **DRUG:** Routine opioid management
- **DEVICE:** PMD-200 Nol-guided opioid administration

## Key facts

- **NCT ID:** NCT04679818
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-30
- **Primary completion:** 2022-12-30
- **Final completion:** 2023-01-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2024-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04679818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04679818, "Postoperative Consequences of Intraoperative NOL Titration". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04679818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*